EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy (Q34296575)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy
scientific article

    Statements

    EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy (English)
    Deliang Guo
    Daisuke Kuga
    Akio Iwanami
    Horacio Soto
    Kelly Y Lin
    Tiffany T Huang
    David Akhavan
    M Benjamin Hock
    Shaojun Zhu
    Ava A Kofman
    Steve J Bensinger
    William H Yong
    Andrew D Watson
    John G Kuhn
    H Ian Robins
    Michael D Prados
    Ingo K Mellinghoff
    Paul S Mischel
    15 December 2009

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit